"Competitive Regional Clusters: National Policy Approaches" analyses the objectives, targeting, instruments and inter-governmental role sharing used by 26 programmes in 14 OECD countries.
This working paper identifies the sources of changes in German international price competitiveness over the past 30 years.
Summarises proceedings of a conference looking at examples of human genetic research databases, how they are established, how they are managed and governed, how they might be commercialised, and what the policy considerations might be.
This seminar is organised in cooperation with INAS CISL and Fondazione Giulio Pastore. The event will present and discuss the results of research addressing these issues undertaken in eight European countries: Italy, Spain, France, Germany, Belgium, Great Britain, Sweden and Poland.For each country, the research provides an overview of the changes in the trade union movement, not only as an actor in labour market bargaining, but also
Labour market reform in Germany needs to be followed up in order to raise the economy's capacity to generate employment, as discussed in this working paper.
German, , 334kb
This note (in German) summarizes the main characteristics of the Germany's education system. The full edition “Education at a Glance: 2006” provides a comparable and up-to-date array of education indicators enabling countries to see themselves in the light of other countries' performance.
This working paper sugggest that much scope remains to make regulation of product markets more conducive to competition - notwithstanding progress in recent years - with substantial benefits for consumer welfare, productivity and employment.
This site contains a list of key references on Germany. The documentary database includes documents on partnership and local governance that have been published by governments, universities and other organisations.
This publication presents reviews of the labour market integration of immigrants and their children in four OECD countries (Australia, Denmark, Germany and Sweden), and provides country-specific recommendations.
This publication examines the innovation system in pharmaceutical biotechnology in eight OECD countries. Based on rich evidence, it draws policy recommendations to foster innovation in biopharmaceuticals advocating an integrated policy approach.